Orphan Medicines for Pediatric Use: A Focus on the European Union-Reference-Cited by-同舟云学术

Orphan Medicines for Pediatric Use: A Focus on the European Union

Published:2019-12 Issue:12 Volume:41 Page:2630-2642
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Bolislis Winona Rei,Corriol-Rohou Solange,Hill-Venning Claire,Hoogland Hans,Joos Angelika,King David,Kitcatt Victoria,Le Visage Genevieve,Kühler Thomas C.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. International Federation of Pharmaceutical Manufacturers & Associations. Rare diseases: shaping a future with no-one left behind. IFPMA; February 28, 2017. https://www.ifpma.org/resourcecentre/rare-diseases-shaping-a-future-with-no-one-leftbehind/. Accessed March 20, 2019.

2. New drugs for rare diseases in children;Rose;Clin Ther,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Potential Challenges for Developing Generic Orphan Drugs for Rare Diseases: A Survey of US and European Markets;Value in Health Regional Issues;2023-05

2. Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia;Drug Discovery Today;2022-09

3. Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities;Pharmaceutics;2021-12-17

4. Assessment of Drugs Approved by Public Knowledge‐Based Applications ( Kouchi‐shinsei ) During the Last Two Decades in Japan;Clinical Pharmacology & Therapeutics;2021-07-02

5. Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison;Healthcare;2021-03-08